EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension

Mohammad Y Alshahrani iD, Hasnaa A Ebrahim iD, Saeed M Alqahtani, Nervana M Bayoumy, Samaa S Kamar, Asmaa M ShamsEldeen iD, Mohamed A Haidara iD, Bahjat Al-Ani iD, Alia Albawardi iD

Molecules · 18.03.2023 · 28 (6) · 2756

DOI: 10.3390/molecules28062756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 18.03.2023. Verfasst von Mohammad Y Alshahrani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 61413, Saudi Arabia. Hauptthemen laut MEDLINE: Metformin, Renal Insufficiency, Chronic, Hypertension, Dyslipidemias. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University Researchers Supporting Project, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, Research Deanship of King Khalid University, Abha, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxic chemicals such as carbon tetrachloride and thioacetamide (TAA) are reported to induce hepato-nephrotoxicity. The potential protective outcome of the antidiabetic and pleiotropic drug metformin against TAA-induced chronic kidney disease in association with the modulation of AMP-activated protein kinase (AMPK), oxidative stress, inflammation, dyslipidemia, and systemic hypertension has not been investigated before. Therefore, 200 mg/kg TAA was injected (via the intraperitoneal route) in a model group of rats twice a week starting at week 3 for 8 weeks. The control rats were injected with the vehicle for the same period. The metformin-treated group received 200 mg/kg metformin daily for 10 weeks, beginning week 1, and received TAA injections with dosage and timing similar to those of the model group. All rats were culled at week 10. It was observed that TAA induced substantial renal injury, as demonstrated by significant kidney tissue damage and fibrosis, as well as augmented blood and kidney tissue levels of urea, creatinine, inflammation, oxidative stress, dyslipidemia, tissue inhibitor of metalloproteinases-1 (TIMP-1), and hypertension. TAA nephrotoxicity substantially inhibited the renal expression of phosphorylated AMPK. All these markers were significantly protected by metformin administration. In addition, a link between kidney fibrosis and these parameters was observed. Thus, metformin provides profound protection against TAA-induced kidney damage and fibrosis associated with the augmentation of the tissue protective enzyme AMPK and inhibition of oxidative stress, inflammation, the profibrogenic gene TIMP-1, dyslipidemia, and hypertension for a period of 10 weeks in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminRenal Insufficiency, ChronicHypertensionDyslipidemiasRatsAnimalsAMP-Activated Protein KinasesThioacetamideTissue Inhibitor of Metalloproteinase-1Up-RegulationDown-RegulationOxidative StressInflammationFibrosisLiverLiver Cirrhosis

Stichwörter der Autor:innen

AMPKTIMP-1chronic kidney diseasedyslipidemiahypertensioninflammationmetforminoxidative stressrenal fibrosisthioacetamide

Substanzen

MetforminAMP-Activated Protein KinasesThioacetamideTissue Inhibitor of Metalloproteinase-1

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 61413, Saudi Arabia.
  • Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
  • Department of Surgery, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia.
  • Department of Physiology, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.
  • Department of Histology, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo 11566, Egypt.
  • Histology Department, Armed Forces College of Medicine, Cairo 11566, Egypt.

ORCID-Profile: Mohammad Y Alshahrani, Hasnaa A Ebrahim, Asmaa M ShamsEldeen, Mohamed A Haidara, Bahjat Al-Ani, Alia Albawardi

Förderung

  • Princess Nourah bint Abdulrahman University Researchers Supporting Project
  • Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
  • Research Deanship of King Khalid University, Abha, Saudi Arabia

Zitieren

APA

Alshahrani, M. Y., Ebrahim, H. A., Alqahtani, S. M., Bayoumy, N. M., Kamar, S. S., ShamsEldeen, A. M., Haidara, M. A., Al-Ani, B., & Albawardi, A. (2023). Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension. Molecules, 28(6), 2756. https://doi.org/10.3390/molecules28062756

Vancouver

Alshahrani MY, Ebrahim HA, Alqahtani SM, Bayoumy NM, Kamar SS, ShamsEldeen AM, et al. Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension. Molecules. 2023;28(6):2756. doi:10.3390/molecules28062756

BibTeX
@article{Alshahrani2023,
  author = {Alshahrani, Mohammad Y and Ebrahim, Hasnaa A and Alqahtani, Saeed M and Bayoumy, Nervana M and Kamar, Samaa S and ShamsEldeen, Asmaa M and Haidara, Mohamed A and Al-Ani, Bahjat and Albawardi, Alia},
  title = {Metformin Suppresses Thioacetamide-Induced Chronic Kidney Disease in Association with the Upregulation of AMPK and Downregulation of Oxidative Stress and Inflammation as Well as Dyslipidemia and Hypertension},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {6},
  pages = {2756},
  doi = {10.3390/molecules28062756}
}
Kostenlos starten →